DIA
TTOO

Denver Investment Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Denver Investment Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2
Closed -$103K – 487
2016
Q1 		$103K Buy
+2
New +$88.4K ﹤0.01% 435

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Denver Investment Advisors's TTOO Position: Q2 2016 in Review

Denver Investment Advisors sold out of T2 Biosystems, Inc (TTOO) in Q2 2016, closing a stake of 2 shares — an estimated $103K sold.

Denver Investment Advisors first reported a position in TTOO in Q1 2016 and held it in 1 quarter. The position peaked at $103K in Q1 2016. 48 funds tracked by Wall St. Rank hold TTOO as of Q2 2016.

  • Denver Investment Advisors reported no remaining T2 Biosystems, Inc position as of Q2 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 2 T2 Biosystems, Inc shares in Q2 2016, an estimated $103K.
  • Denver Investment Advisors first reported a position in T2 Biosystems, Inc in Q1 2016 and held it in 1 quarter.
  • Denver Investment Advisors's T2 Biosystems, Inc position peaked at $103K in Q1 2016.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2016.

Based on Denver Investment Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.